Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects

1. Apomorphine HC1 (Apo) (0.25 0.5 or 0.75 mg sc), a dopamine (DA) receptor agonist, induced penile erections (PEs) (monitored by mercury strain gauges and continuous recording on paper strip charts) in 7 out of 9 normal subjects and placebo in 1 of these 9 (p 2. Apo-induced PEs recurred in each of the 6 subjects retested. 3. Benztropine (2 mg iv) had no effect on Apo-induced penile tumescence (PT). 4. These data suggest (a) DA mechanisms play a role in normal erectile function (b) DA-mediated PT is not modulated by cholinergic systems (c) evaluation of the erectile response to Apo may provide a simple ancillary test to the investigation of impotence and a way of identifying a subpopulation of impotent subjects with impaired DA function who may respond to long-acting DA agents (d) Apo-induced PT may provide a novel way of studying DA function in man.